Hypertension
Conditions
Interventions
This is a randomized controlled clinical trial with three parallel arms, double-blind. A total of 70 seniors who meet the eligibility criteria will be probabilistically allocated to one of three inter
Experimental Group II (PEG): 40 elderly people of both genders with systemic arterial hypertension will undergo face-to-face training and participate in lectures on health and a healthy lifestyle
Control group (CG): 10 elderly people of both genders with arterial hypertension will participate in lectures on health and a healthy lifestyle. The training program for the REG and PEG will consist o
G11.427.410.698.277
Sponsors
Universidade Federal da Paraiba
Universidade Federal da Paraiba
Eligibility
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: Volunteers of both genders; 60 years of age or older; arterial hypertension in stages I and II; body mass index less than 34.9 kg/m2
Exclusion criteria
Exclusion criteria: Smoking volunteers; morbid obesity; respiratory and heart disease; peripheral arterial disease; musculoskeletal diseases that make it impossible to practice physical exercise; participate in another physical training protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a mean difference in blood pressure of at least 5mmHg, assessed by Ambulatory Blood Pressure Monitoring (ABPM) and office measurement. The ABPM measurement will be performed one week before the beginning of the intervention, in the eighth week and after the end of the 16-week intervention. Office blood pressure collection will be evaluated at each training session. ;It is expected to find a reduction of up to 5 minutes in sleep latency and a 10% increase in sleep efficiency determined by Actimetry. Both parameters will be evaluated one week before the start of the intervention and after the end of the 16-week intervention. ;It is expected to find a reduction in left ventricular mass index of at least 4 g/m2 assessed by 3D Doppler one week before the start of the intervention and after the end of the 16-week intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| A 15% increase in functional fitness assessed by the Rikli Jones battery is expected, which will be assessed before the intervention, in the eighth week and after the end of the 16-week intervention.;A 5% reduction in depressive symptoms assessed by the Geriatric Depression Scale is expected one week before the start of the intervention, in the eighth week and after the end of the 16-week intervention.;An increase of 10% is expected in functional capacity and vitality related to quality of life, which will be assessed by the WHOqol-Old Questionnaire one week before the start of the intervention, in the eighth week and after the end of the 16-week intervention.;A 5% reduction in body fat is expected, assessed by the Bioimpedance method, which will be collected one week before the start of the intervention, in the eighth week and after the end of the 16-week intervention. | — |
Countries
Brazil
Contacts
Public ContactMaria do Socorro Brasileiro-Santos
Laboratório de Estudos do Treinamento Fisico Aplicado a Saúde /Universidade Federal da Paraíba
Outcome results
None listed